Skip to main content
. 2021 Jan 7;10(2):193. doi: 10.3390/jcm10020193

Figure 3.

Figure 3

A flow chart showing the progression from KTx to premature graft loss. cfDNA may be a biomarker indicative of graft injury at a very early stage.